SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Regeneron Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?

To: Larry Liebman who wrote (387)2/23/2000 9:55:00 AM
From: satish kamat  Respond to of 3557
 
biz.yahoo.com

.. with three product candidates in late-stage trials and an outstanding new product pipeline, believe that Regeneron's stock is undervalued relative to its peers...

It was even more undervalued at 12.



To: Larry Liebman who wrote (387)2/23/2000 10:57:00 AM
From: nigel bates  Read Replies (2) | Respond to of 3557
 
Now that's what I call accumulation...

nig



To: Larry Liebman who wrote (387)2/23/2000 8:19:00 PM
From: Miljenko Zuanic  Respond to of 3557
 
M.L. who??? Mr. Schleifer's brother in law?

Go Schleifer, go!

.... you know...,

Well, if I am boring, how about this:

"Oj Schleifer Rajska Ptico sto te muci da si zamuckao!"

Miljenko

PS: The irony is that Erick (who was against *small* bios) has to recommend REGN while others are sitting on their ass (trying to figure out which next gen.com to hype).


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News